340 related articles for article (PubMed ID: 32059422)
1. Salivary Redox Biomarkers in Selected Neurodegenerative Diseases.
Maciejczyk M; Zalewska A; Gerreth AK
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32059422
[TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
[TBL] [Abstract][Full Text] [Related]
3. The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease.
Pawlik P; Błochowiak K
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33671562
[TBL] [Abstract][Full Text] [Related]
4. Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases.
Schepici G; Silvestro S; Trubiani O; Bramanti P; Mazzon E
Brain Sci; 2020 Apr; 10(4):. PubMed ID: 32326227
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Islam MT
Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
[TBL] [Abstract][Full Text] [Related]
6. ASK1 in neurodegeneration.
Guo X; Namekata K; Kimura A; Harada C; Harada T
Adv Biol Regul; 2017 Dec; 66():63-71. PubMed ID: 28882588
[TBL] [Abstract][Full Text] [Related]
7. Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection.
Goldoni R; Dolci C; Boccalari E; Inchingolo F; Paghi A; Strambini L; Galimberti D; Tartaglia GM
Ageing Res Rev; 2022 Apr; 76():101587. PubMed ID: 35151849
[TBL] [Abstract][Full Text] [Related]
8. Emergence of breath testing as a new non-invasive diagnostic modality for neurodegenerative diseases.
Subramaniam NS; Bawden CS; Waldvogel H; Faull RML; Howarth GS; Snell RG
Brain Res; 2018 Jul; 1691():75-86. PubMed ID: 29684335
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential.
Bai Y; Su X; Piao L; Jin Z; Jin R
Front Mol Neurosci; 2021; 14():556215. PubMed ID: 33815055
[TBL] [Abstract][Full Text] [Related]
10. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
11. Salivary biomarkers for the diagnosis and monitoring of neurological diseases.
Farah R; Haraty H; Salame Z; Fares Y; Ojcius DM; Said Sadier N
Biomed J; 2018 Apr; 41(2):63-87. PubMed ID: 29866603
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases.
Gao P; Li X; Du X; Liu S; Xu Y
Front Aging Neurosci; 2021; 13():790863. PubMed ID: 34975460
[TBL] [Abstract][Full Text] [Related]
13. Natural Compounds Preventing Neurodegenerative Diseases Through Autophagic Activation.
Huang Z; Adachi H
J UOEH; 2016 Jun; 38(2):139-48. PubMed ID: 27302727
[TBL] [Abstract][Full Text] [Related]
14. Salivary Biomarkers of Oxidative Stress and Inflammation in Stroke Patients: From Basic Research to Clinical Practice.
Maciejczyk M; Bielas M; Zalewska A; Gerreth K
Oxid Med Cell Longev; 2021; 2021():5545330. PubMed ID: 33897941
[TBL] [Abstract][Full Text] [Related]
15. Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development.
Bhat SA; Kamal MA; Yarla NS; Ashraf GM
Curr Top Med Chem; 2017; 17(12):1371-1378. PubMed ID: 28017151
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid system in neurodegenerative disorders.
Basavarajappa BS; Shivakumar M; Joshi V; Subbanna S
J Neurochem; 2017 Sep; 142(5):624-648. PubMed ID: 28608560
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application.
Xu J; Du W; Zhao Y; Lim K; Lu L; Zhang C; Li L
Acta Pharm Sin B; 2022 Jun; 12(6):2778-2789. PubMed ID: 35755284
[TBL] [Abstract][Full Text] [Related]
18. Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects.
Faysal M; Dehbia Z; Zehravi M; Sweilam SH; Haque MA; Kumar KP; Chakole RD; Shelke SP; Sirikonda S; Nafady MH; Khan SL; Nainu F; Ahmad I; Emran TB
Neurochem Res; 2024 Jun; ():. PubMed ID: 38822985
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases.
Attia MS; Yahya A; Monaem NA; Sabry SA
Saudi Pharm J; 2023 Mar; 31(3):417-432. PubMed ID: 37026045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
